Better Treatment At What Cost? A Study Of Myeloma Spending.
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
60Background: Multiple myeloma represents less than 1.5% of new cancer cases in Canada. Currently, the estimated median overall survival is at least 5-6 years, primarily driven by therapeutic advan...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要